GB0516058D0 - New protein isoforms and uses thereof - Google Patents

New protein isoforms and uses thereof

Info

Publication number
GB0516058D0
GB0516058D0 GBGB0516058.5A GB0516058A GB0516058D0 GB 0516058 D0 GB0516058 D0 GB 0516058D0 GB 0516058 A GB0516058 A GB 0516058A GB 0516058 D0 GB0516058 D0 GB 0516058D0
Authority
GB
United Kingdom
Prior art keywords
new protein
protein isoforms
isoforms
new
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0516058.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Genome Sciences UK Ltd
Original Assignee
Oxford Genome Sciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Genome Sciences UK Ltd filed Critical Oxford Genome Sciences UK Ltd
Priority to GBGB0516058.5A priority Critical patent/GB0516058D0/en
Publication of GB0516058D0 publication Critical patent/GB0516058D0/en
Priority to US11/989,828 priority patent/US20100223678A1/en
Priority to PCT/GB2006/050232 priority patent/WO2007015113A2/en
Priority to JP2008524596A priority patent/JP2009506301A/ja
Priority to EP06765380A priority patent/EP1987356A2/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GBGB0516058.5A 2005-08-04 2005-08-04 New protein isoforms and uses thereof Ceased GB0516058D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0516058.5A GB0516058D0 (en) 2005-08-04 2005-08-04 New protein isoforms and uses thereof
US11/989,828 US20100223678A1 (en) 2005-08-04 2006-08-04 protein isoforms of the pif-family and uses thereof
PCT/GB2006/050232 WO2007015113A2 (en) 2005-08-04 2006-08-04 New protein isoforms of the pif-family and uses thereof
JP2008524596A JP2009506301A (ja) 2005-08-04 2006-08-04 Ｐｉｆファミリーの新たなタンパク質アイソフォーム及びその使用
EP06765380A EP1987356A2 (en) 2005-08-04 2006-08-04 New protein isoforms of the pif-family and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0516058.5A GB0516058D0 (en) 2005-08-04 2005-08-04 New protein isoforms and uses thereof

Publications (1)

Publication Number Publication Date
GB0516058D0 true GB0516058D0 (en) 2005-09-14

Family

ID=34984093

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0516058.5A Ceased GB0516058D0 (en) 2005-08-04 2005-08-04 New protein isoforms and uses thereof

Country Status (5)

Country Link
US (1) US20100223678A1 (enExample)
EP (1) EP1987356A2 (enExample)
JP (1) JP2009506301A (enExample)
GB (1) GB0516058D0 (enExample)
WO (1) WO2007015113A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2502628B1 (en) 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
WO2010096331A1 (en) 2009-02-11 2010-08-26 Duke University Sensors incorporating antibodies and methods of making and using the same
JP5433341B2 (ja) * 2009-08-04 2014-03-05 ホーユー株式会社 等電点電気泳動方法及び粗雑物除去の判定方法
JP5190423B2 (ja) * 2009-08-04 2013-04-24 ホーユー株式会社 ２次元電気泳動方法
DK3173427T3 (da) 2011-03-31 2019-08-05 Adc Therapeutics Sa Antistoffer mod nyre-associeret antigen 1 og antigen-bindende fragmenter deraf
MX2014002144A (es) * 2011-08-26 2014-03-31 Hoffmann La Roche Metodo para predecir el beneficio clinico del tratamiento de los transtornos del desarrollo neurologico, neurologicos o neuropsiquiatricos.
HRP20190946T1 (hr) 2012-01-09 2019-07-26 Adc Therapeutics Sa Sredstva za liječenje trostruko negativnog raka dojke
US9244946B2 (en) 2012-11-26 2016-01-26 International Business Machines Corporation Data mining shape based data
US10407716B2 (en) 2014-03-13 2019-09-10 Duke University Electronic platform for sensing and control of electrochemical reactions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319687B1 (en) * 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
US6613740B1 (en) * 1997-02-07 2003-09-02 Ramot University Authority For Applied Research And Industrial Development Ltd. Activity dependent neurotrophic factor III (ADNF III)
US20040038877A1 (en) * 2001-10-02 2004-02-26 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1408333A3 (en) * 2001-10-03 2006-10-25 Pfizer Products Inc. Diagnosis and treatment of Alzheimer's disease
AU2003235789A1 (en) * 2002-01-11 2003-07-24 Xantos Biomedicine Ag Novel apoptosis-inducing dna sequences
US20090162363A1 (en) * 2003-08-07 2009-06-25 Sofia Patricia Becerra Pedf-r receptor and uses
JP2005132738A (ja) * 2003-10-28 2005-05-26 Protein Express:Kk アルツハイマー病のタンパク質分子レベルにおける検出方法

Also Published As

Publication number Publication date
JP2009506301A (ja) 2009-02-12
US20100223678A1 (en) 2010-09-02
WO2007015113A3 (en) 2007-12-27
EP1987356A2 (en) 2008-11-05
WO2007015113A2 (en) 2007-02-08

Similar Documents

Publication Publication Date Title
PL1940240T3 (pl) Kompozycje izolatu białka i ich zastosowania
IL185547A0 (en) Lipocalin protein
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1960523A4 (en) MODIFIED POREN FORMING PROTEIN TOXINS AND USE THEREOF
GB0516058D0 (en) New protein isoforms and uses thereof
GB0422901D0 (en) Lipocalin protein
GB0522667D0 (en) New protein isoforms and uses thereof
EP1922328A4 (en) PEPTIDES TARGETED ON C PROTEIN KINASE ISOFORMS AND USE THEREOF
GB0614911D0 (en) New protein isoforms and uses thereof
GB0505620D0 (en) Methods and materials therefor
GB0516571D0 (en) Novel polypeptides and uses thereof
GB0504229D0 (en) New polypeptide uses thereof and methods employing it
GB0401882D0 (en) Protein
GB0502843D0 (en) Jig-was and jig-will
GB0401303D0 (en) Polypeptide and uses thereof
GB0503093D0 (en) Ricin-binding peptide and methods for use thereof
GB0523949D0 (en) Recombinant bacteria and uses thereof
IL179998A0 (en) Chimeric proteins and uses thereof
GB0417390D0 (en) Chimeric proteins and uses thereof
GB0523266D0 (en) Materials and methods
GB0513690D0 (en) Protein
GB0504075D0 (en) Plac-1-like protein
GB0513561D0 (en) Protein
GB0508160D0 (en) Protein
GB0514717D0 (en) Protein

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)